Singapore develops antibody test to detect novel coronavirus infection, disease

Antibodies produced by the immune system in response to infection will be present in the blood for a long time

Updated - February 26, 2020 02:35 pm IST

Published - February 26, 2020 01:34 pm IST - CHENNAI

Photo used for representational purpse only. File

Photo used for representational purpse only. File

Using an antibody test developed by the Duke-NUS Medical School that relies on blood samples, the Singapore Ministry of Health has been successful in identifying two people who were infected with the novel coronavirus (SARS-CoV-2) and have since recovered. The antibody test can be used for detecting people infected with novel coronavirus but are asymptomatic or exhibit only mild symptoms. The Singapore Ministry of Health announced this during a press conference on Tuesday.

In an email to The Hindu , Danielle Anderson, Scientific Director of the Duke-NUS ABSL3 facility, said the “sensitivity and specificity should be 100% since we have two parallel tests to ensure that we do not capture false negatives/positives.”

Unlike the currently used molecular test that detects the presence of viral genetic material in oral swab samples, the diagnostic test developed by Duke-NUS Medical School detects antibodies developed by the immune system when infected with the novel coronavirus.

“Antibodies will start appearing in the body starting a few days after infection and will peak in about two-three weeks after infection. [So] The test may not be able to detect antibodies if the person is tested too soon after infection,” Dr. Anderson explained.

While the currently used molecular test has low sensitivity and cannot identify people who have recovered from COVID-19 illness as they will no longer harbour the virus, antibodies produced by the immune system in response to infection will be present in the blood for a long time. This makes the antibody test particularly important to trace even people who have recovered from illness.

“We developed assays which are not new assays but using them in this context we could look for antibodies in patients. We could trace back patients who have been infected previously,” Dr. Anderson said during the press conference.

Explaining how the antibody test is carried out, Dr. Anderson said in the email: “The live coronavirus is tested against the antibodies present in the patients’ samples. If there are antibodies against the coronavirus, the antibodies will prevent the coronavirus from replicating. This is a definitive readout of the patient being previously infected by the virus because you will not have antibodies against the virus if you have never been infected by it before.”

On January 30, the Duke-NUS Medical School announced that in collaboration with other institutions/hospital it had successfully cultured the novel coronavirus from an infected person, thus becoming the third country outside China to do so. 

According to the Ministry of Health release, the researchers had used the virus and genetic material derived from the virus to “develop several specific laboratory tests to detect the virus-specific antibodies for contact tracing and other applications”. 

The antibody test was put to use to confirm past infection (late January) with novel coronavirus in two people who have since recovered. Two different antibody testing platforms (virus neutralisation assay and ELISA assay) were used to confirm past infection. This became possible as these people, despite having recovered from COVID-19 illness, still had “very high levels of the virus-specific antibodies in their blood”.

The positive test result in the two people helped the Health Ministry to establish the links between two church clusters and the source of infection.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.